fluidsandelectrolytes-090305183533-phpapp01
TRANSCRIPT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 1/132
Fluids
and
Electrolytes
Ma. Tosca Cybil A. Torres, RN
HYPERPOLMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 2/132
OBJECTIVESAfter this lecture/discussion, the learner should be able to:
1. Describe the mechanisms that maintain fluid, electrolyte and
acid-base balance.2. Compare the mechanisms and effects of fluid deficit andexcess.
3. Discuss the mechanisms and effects of deficits and excess.
4. Describe the mechanisms that maintain acid-base balance.
5. Differentiate between metabolic and respiratory acidosis andalkalosis.
6. Apply the pathophysiologic principles of acid-base balance tothe interpretation of ABG measurements.
7. Analyze the components of ABGs to identify the type of acid-base balance.
8. Describe the causes and effects of each type of acid-basebalance.
9. Use ABG findings in formulating the care of the patient with anacid-base imbalance.
10. Describe the management of patients with a fluid, electrolyte, or
acid-base imbalance.
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 3/132
Fluids
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 4/132
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 5/132
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 6/132
↓Bloodvolumeor ↓BP
Volume receptorAtria and great veins
Hypothalamus
↓
Posteriorpituitary gland
Osmoreceptors inhypothalamus
↑Osmolarity
↑ADH Kidneytubules
↑H2O
reabsorption
↑vascular
volume and↓osmolarity
Narcotics, Stress,Anesthetic agents, Heat,Nicotine, Antineoplastic
agents, Surgery
ANTIDIURETIC HORMONE REGULATION MECHANISMS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 7/132
Juxtaglomerularcells-kidney
↓Serum Sodium
↓Blood volume
Angiotensin I
Kidney tubules
Angiotensin II
Adrenal Cortex
↑Sodium
resorption(H2O resorbed
with sodium); ↑Blood volume
Angiotensinogen inplasma
RENIN
Angiotensin-converting
enzyme
ALDOSTERONE
Intestine, sweatglands, Salivary
glands
Via vasoconstriction of arterial smooth muscle
ALDOSTERONE-RENIN-ANGIOTENSIN SYSTEM
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 8/132
Fluid Types
• Fluids in the body generally aren’t
found in pure forms
• Isotonic, hypotonic, and hypertonictypes
• Defined in terms of the amount ofsolute or dissolve substances in thesolution
• Balancing these fluids involves theshifting of fluid not the solute involved
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 9/132
Isotonic Solutions
• No net fluid shiftsoccur between isotonic
solutions because thesolution are equallyconcentrated
• Ex. NSS or 0.9SS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 10/132
Hypotonic Solutions
• Has a lower soluteconcentration thananother solution
• Fluid from thehypotonic solutionwould shift into thesecond solution until
the two solutions hadequal concentrations
• Ex. Half normal or0.45%SS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 11/132
Hypertonic Solutions
• Has a higher soluteconcentration thananother solution
• Fluid from the secondsolution would shiftinto the hypertonicsolution until the two
solutions had equalconcentrations
• Ex. D5NSS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 12/132
Fluid Movements
• Fluids and solutes constantly move withinthe body, which allows the body to maintainhomeostasis
• Fluids along with nutrients and wasteproducts constantly shift within the body’s
compartments from the cell to the interstitial
spaces, to the blood vessels and back again
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 13/132
Fluid Movements
• Types of Transport
– A. Active transport
– B. Passive transport
• Diffusion
• Osmosis
• Filtration
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 14/132
Assessment• CLINICAL MEASUREMENT
– Daily weights• Each kg = 1 L of fluid• To gain accuracy:
– Balance the scale before each use and weigh the client;» At same time each day before breakfast after the first void» Wear the same or similar clothing» On the same scale
– Vital signs• Tachycardia – first sign of hypovolemia
– Fluid I & O• Oral fluids• Ice chips• Foods that tend to become fluid at room temperature• Tube feedings• Parenteral fluids• IV meds
• Catheter or tube irrigant
• Urinary output – if with diaper, 1 g = 1 mL• Vomitus or liquid feces• Diaphoresis• Tube drainage• Wound dressing or wound fistula
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 15/132
LABORATORY TESTS FOR EVALUATINGFLUID STATUS
• Osmolality – measures the solute concentration perkilogram in blood and urine.
• Osmolarity – concentration of solution per liter.• BUN – (10-20 mg/dL)made up of urea, an end product of
protein metabolism by the liver.• Creatinine (0.7 to 1.5 mg/dL)- end product of musclemetabolism
• Serum electrolytes• CBC
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 16/132
Diagnosis
• Fluid volume deficit
• High risk for Fluid volume deficit
• Fluid volume excess
• Altered oral mucous membrane
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 17/132
FLUID BALANCE• The desirable amount of fluid intake and loss in adults ranges from
1500 to 3500 mL each 24 hours. Ave= 2500 mL
• Normally INTAKE = OUTPUT
FLUID IMBALANCE• Changes in ECF volume = alterations in sodium balance
• Change in sodium/water ratio = either hypoosmolarity orhyperosmolarity
• Fluid excess or deficit = loss of fluid balance
• As with all clinical problems, the same pathophysiologic change isnot of equal significance to all people
• For example, consider two persons who have the same viral
syndrome with associated nausea and vomiting
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 18/132
FLUID DEFICIT/HYPOVOLEMIA
• May occur as a result of:
– Reduced fluid intake
– Loss of body fluids – Sequestration (compartmentalizing) of body fluids
Pathophysiology and Clinical Manifestations
DECREASED FLUID VOLUME
Stimulation of thirstcenter in hypothalamus
Person complains of thirst
↑ ADH Secretion
↑ Water resorption
↓ Urine Output
Renin-Angiotensin-
Aldosterone System
Activation
↑ Sodium and
Water Resorption
↑ Urine specific gravity
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 19/132
Pathophysiology and Clinical Manifestations
UNTREATED FLUID VOLUME DEFICIT
Depletion of fluids available
↑ BODY TEMPERATURE
Dry mucous membranes
Difficulty with speech
Cells become unable to continue
providing water to replace ECF
losses
Signs of circulatory collapse
↓ blood pressure
↑ heart rate
↑ respiratory rate
Restlessness and Apprehension
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 20/132
Hypovolemia
• Nursing Intervention – Monitor fluid intake and output – Checked daily weight (a 1lb(0.45kg) weight loss equals a 500 ml
fluid loss) – Monitor hemodynamic values such as CVP
– Monitor results of laboratory studies – Assess level of consciousness – Administer and monitor I.V. fluids – Apply and adjust oxygen therapy as ordered – If patient is bleeding, apply direct continuous pressure to the area
and elevate it if possible – Assess skin turgor – Assess oral mucous membranes – Turn the patient at least every 2 hours to prevent skin breakdown
– Encourage oral fluids
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 21/132
Hypovolemia
• Warning Signs – Cool pale skin over the arms and legs
– Decreased central venous pressure
– Delayed capillary refill
– Deterioration in mental status flat jugular veins – Orthostatic hypotension
– Tachycardia
– Urine output initially more than 30ml/min, then dropping below10ml/hour
– Weak or absent peripheral pulses
– Weight loss
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 22/132
Collaborative Care Management
Identification of vulnerable patients and risk factors:
* Compromised mental state
* Physical limitations* Disease states
* Limited access to adequate food and fluids
Development of a plan of care
Family members should
be educated about the
importance of fluid and
nutrition intake
Collaboration with the
nurse, patient, family
members, and other
health care providers
for continuedassessment and
treatment of problems
Ongoing assessment and
detailed action plan of
fluid and serum
electrolyte balance.
Factors such asmedications (particularly
diuretics),
hyperventilation, fever,
burns, diarrhea, and
diabetes with
appropriate referral
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 23/132
Collaborative Care Key Points• 1 Liter of water = 1 kg of water by weight
• Fluid replacement are calculated according to this ratio plus 1.5 L tofulfill the current daily needs
• For example, JUAN, a one-year-old, lost 1 kg of water from diarrhea asweighed from his diaper over the last 24 hours. Therefore, since 1kg=1 L, fluid replacement therapy for him will involve 1 L of fluids +1500 L.
• Oral fluid resuscitation is preferable but if the patient is unable totolerate fluids, IV Therapy may be ordered
• Vital signs should be assessed regularly• Postural hypotension is common for postural persons with fluid
volume deficit. How do we assess this?
• For example, in the care of LOIDA, a 31 year old with severe DHN, youtake her blood pressure (130/80) and pulse (75) while she’s lyingdown. Then you ask her to sit at the edge of bed. When you take her
blood pressure again, you get 115/80 and when you take her pulse,you get 80. This is consistent with intravascular volume depletion.
• Daily weighing is also useful to monitor fluid and electrolyte balance
• Laboratory results should be reviewed for various fluid and electrolytedisturbances so that appropriate adjustments to therapy can beinitiated
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 24/132
Fluid Replacement Therapy
• Aimed at restoring and maintaining homeostasis
• Methods:
– Oral and gastric feeding
– Parenteral therapy
• Choice of therapy affected by several factors
– Type and severity of imbalance
– Patient’s overall health status, age, renal and
cardiovascular status – Usual maintenance requirements
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 25/132
Fluid Replacement Therapy
Advantages – Provides the patient with life-sustainingfluids, electrolytes, and drugs
– Immediate and predictable therapeutic
effects – Preferred for administering fluids,
electrolytes, and drugs in emergencysituations
– Allows fluid intake when a patient has GImalabsorption
– Permits accurate dosage titration foranalgesics and other drugs
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 26/132
Fluid Replacement Therapy
Disadvantages
– Solution incompatibility
– Adverse reactions
– Infection
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 27/132
Fluid Replacement Therapy
Administration routes
– Oral route : oral ingestion of fluids and electrolytes asliquids or solids administered directly into the GI tract
– Nasogastric route: instillation of fluids and electrolytesthrough feeding tubes, such as NG, gastrostomy andjejunostomy tubes
– I.V. route: administration of fluids and electrolytesdirectly into the bloodstream using continuousinfusion, bolus, or I.V. push injection throughperipheral or central venous site
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 28/132
Which among the following IV
solutions contains the highestpotassium content?
A. D5 IMBB. Lactated Ringer's Solution
C. D5 LRSD. D5 0.3 NaCl
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 29/132
Composition of Different Intravenous Solution
IVF Dextrose
(g/L)Na
(meq/L)Cl
(meq/L)K
(meq/L)Lactate
(meq/L)
D5 0.9% NaCl 50 154 154
D5 0.15% NaCl 50 25 25
D5 0.3% NaCl 50 51 51
D5 0.45% NaCl 50 77 77
D5 IMB 50 25 22 20 23
LRS 0 130 109 4 28
NSS 0 154 154
D5LRS 50 130 109 4 28
Fluid Replacement Therapy
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 30/132
Fluid Replacement Therapy
ISOTONIC SOLUTION
Facts Examples Uses
-same osmolality as plasma(app. 275 to 295 mOsm/kg)
-vascular space osmolality notaltered by infusion
-expand intracellular andextracellular space equally;degree of expansion correlateswith amount of fluid infused
-no solution-related shifting
between ICF and ECF spaces
-cells neither shrink nor swellwith fluid movement
Dextrose 5% inwater,
Normal SalineSolution,
Lactated RingersSolution
-Fluid loss anddehydration
-Hypernatremia
-Blood transfusion,fluid challenges,resuscitation, shock,metabolic alkalosis,hypercalcemia,
hyponatremia
-Acute blood loss,
burns, dehydration,hypovolemia
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 31/132
Fluid Replacement Therapy HYPOTONIC SOLUTION
Facts Examples Uses
-lower osmolality thanplasma (usually lessthan 275 mOsm/kg)
-hypo-osmolalitypossible with infusionbecause solutions havea lower concentration ofelectrolytes than plasmadoes
-transcend allmembranes fromvascular space to tissueto cell
-cell swells
0.45% sodiumchloride (half-normal salinesolution)
0.3% sodiumchloride
-DKA after initial NSS andbefore dextrose infusion
-gastric fluid loss fromnasogastric suctioning orvomiting
-hypertonic dehydration
-sodium and chloridedepletion
-water replacement
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 32/132
Fluid Replacement Therapy
HYPERTONIC SOLUTION
Facts Examples Uses
-higher osmolality thanplasma (usually > 295mOsm/kg)
-Infusion cansignificantly raisedplasma osmolality
-can cause vascularvolume expansion and
ICF deficit
-Cell shrinks
Dextrose 5% in halfnormal saline solution
Dextrose 5% in normalsaline solution
Dextrose 10% in water
DKA
Addisonian crisis
Hypotonic dehydration
SIADH
Water replacement
FLUID EXCESS/HYPERVOLEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 33/132
FLUID EXCESS/HYPERVOLEMIA
PsychiatricDisorders, SIADH,
Certain head injuries
Dietary SodiumIndiscretion
Renal and endocrinedisturbances,
malignancies, adenomas
OverhydrationExcessive Sodium
Intake
Failure of renal orhormonal regulatory
functions
FLUID VOLUME EXCESS/HYPERVOLEMIA
Si C f i i i
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 34/132
• Since ECF becomes hypoosmolar, fluid moves into the cells to equalize
the concentration on both sides of the cell membrane
• Thus there, is an increase in intracellular fluid
• The brain cells are particularly sensitive to the increase of intracellular
water, the most common signs of hypoosmolar overhydration are
changes in mental status. Confusion, ataxia, and convulsions may also
occur.
• Other clinical manifestations include: hyperventilation, sudden weight
gain, warm, moist skin, increased ICP: slow bounding pulse with an
increase in systolic and decrease in diastolic pressue and peripheral
edema, usually not marked
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 35/132
Hypervolemia
• Evaluating pitting edema
– Press your fingertip firmly into the patients skin over abony surface for a few seconds. Then note the depth of
the imprint your finger leaves on the skin• A slight imprint indicates +1 pitting edema
• A deep imprint, with the skin slow to return to its originalcontour, indicates a +4 pitting edema
• When the skin resists pressure and appears distended, thecondition is called brawny edema, which causes the skin toswell so much that fluid cant be displaced
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 36/132
Hypervolemia
• Diagnostic Findings: – Decreased hematocrit resulting from hemodilution
– Normal serum Na level
– Low serum K and BUN levels
• either due to hemodilution or higher levels may indicate renalfailure
– Low oxygen level
– Abnormal chest x-ray
• Indicates fluid accumulation• May reveal pulmonary edema or pleural effusions
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 37/132
Hypervolemia
• Treatment – Na and fluid intake restriction
– Diuretics to promote excess fluid excretion
– Morphine and nitroglycerin (Nitro-Dur) forpulmonary edema• Dilate blood vessels
• Reduce pulmonary congestion and amount of blood
returning to the heart – Digoxin for heart failure
• Strengthens cardiac contractions
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 38/132
Hypervolemia
• Treatment – Supportive measures
• Oxygen administration
• Bed rest – Hemodialysis or continuous renal replacement
therapy for renal dysfunction
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 39/132
Hypervolemia
• Nursing Interventions – Monitor fluid intake and output – Monitor daily weight – Monitor cardiopulmonary status – Auscultate breathe sounds
– Assess for complaints of dyspnea – Monitor chest x-ray results – Monitor arterial blood gas values – Assess for peripheral edema – Inspect the patient for sacral edema – Monitor infusion of I.V. solutions – Monitor the effects of prescribed medications
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 40/132
Electrolytes
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 41/132
Which one isnot a cation?A. CalciumB. MagnesiumC. PhosphorousD. Sodium
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 42/132
Anions and Cations
• Anions • Cations
BicarbonateChloride
Phosphorous
CalciumMagnesiumPotassiumSodium
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 43/132
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 44/132
WHAT DO ELECTROLYTES DO?
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 45/132
• Controls and regulates volume of body fluids
• Its concentration is the major determinant of ECF volume
• Is the chief electrolyte of ECF
• Influence ICF Volume
•Participates in the generation and transmission of nerve impulses
• Is an essential electrolyte in the sodium-potassium pump
• RDA: not known precisely. 500 mg
• Eliminated primarily by the kidneys, smaller in feces and perspiration
• Salt intake affects sodium concentrations
• Sodium is conserved through reabsorption in the kidneys, a processstimulated by aldosterone
• Normal value: 135-145 mEq/L
HYPONATREMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 46/132
HYPONATREMIA
• Refers to the serum sodium concentration less than 135 mEq/L
• Common with thiazide diuretic use, but may also be seen with
loop and potassium-sparing diuretics as well• Occurs with marked sodium restriction, vomiting and diarrhea,
SIADH, etc. The etiology may be mulfactorial
• May also occur postop due to temporary alteration inhypothalamic function, loss of GI fluids by vomiting or suction, orhydration with nonelectrolyte solutions
• Postoperative hyponatremia is a more serious complication inpremenopausal women. The reasons behind this is unknown
• Therefore monitoring serum levels is critical and careful
assessment for symptoms of hyponatremia is important for allpostoperative patients
PATHOPHYSIOLOGY OF HYPONATREMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 47/132
PATHOPHYSIOLOGY OF HYPONATREMIASodium loss from the intravascular compartment
Diffusion of water into the interstitial spaces
Sodium in the interstitial space is diluted
Decreased osmolarity of ECF
Water moves into the cell as a result of sodium loss
Extracellular compartment is depleted of water
CLINICAL SYMPTOMS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 48/132
CLINICAL MANIFESTATIONS OF HYPONATREMIA
Muscle
Weakness
APATHY
Posturalhypotension
Nausea and
AbdominalCramps
Weight Loss
In severe hyponatremia: mental confusion, delirium, shock and coma
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 49/132
COLLABORATIVE CARE MANAGEMENT• General goal: correct sodium imbalance and restore normal fluid and
electrolyte homeostasis
• Recognition of people at risk for hyponatremia is essential for itsprevention: athletes, persons working in hot environments
• Salt is always replaced along with water
• Management includes educating vulnerable people to recognize signsand symptoms of sodium depletion and maintaining sufficient sodium
and water intake to replace skin and insensible fluid loss• Generally, an increased sodium and water intake provides adequate
treatment
• Education as the importance of sodium and fluid balance and therationale for prescription medications to ensure compliance
• Daily weight. MIO
• Monitoring of sodium levels to determine extent of replacement
• Generally, PNSS or PLRS is prescribed
• Too rapid restoration of sodium balance, hypertonic sodium solutionsmay provoke brain injury
HYPERNATREMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 50/132
HYPERNATREMIA
• A serum sodium level above 145 mEq/L is termed hypernatremia
• May occur as a result of fluid deficit or sodium excess• Frequently occurs with fluid imbalance
• Develops when an excess of sodium occurs without a proportionalincrease in body fluid or when water loss occurs withoutproportional loss of sodium
• Risk Factors: excess dietary or parenteral sodium intake, waterydiarrhea, diabetes insipidus, damage to thirst center, those withphysical or mental status compromise, and people withhypothalamic dysfunction
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 51/132
PATHOPHYSIOLOGY OF HYPERNATREMIA
Increased Sodium concentration in ECF
Osmolarity rises
Water leaves the cell by osmosis and enters thethe extracellular compartments
Dilution of fluids in ECF Cells are water depleted
Suppression of aldosteronesecretion Sodium is exreted in theurine
CLINICAL SYMPTOMS
CLINICAL MANIFESTATIONS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 52/132
CLINICAL MANIFESTATIONS
Dry, sticky mucousmembranes
Firm, rubberytissue turgor
Manic excitement
Tachycardia
DEATH
COLLABORATIVE CARE MANAGEMENT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 53/132
COLLABORATIVE CARE MANAGEMENT
• Recognition of risk factors: bedridden and debilitated patients,diabetes insipidus, fluid deprivation, the elderly and the very
young• A careful and accurate record of MIO permits quick recognition
of negative fluid balance
• People with kidney failure, CHF, or increased aldosteroneproduction may require dietary sodium intake restriction
• Usually, osmolar balance can be restored with oral fluids. If not,the parenteral route may be necessary
• Fluid resuscitation must be undertaken with particular cautionin patients with compromised cardiac or renal function
• The nurse should closely monitor the patient’s response to
fluids and be alert to symptoms of fluid overload
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 54/132
• Major cation of the ICF. Chief regulator of cellular enzyme activity andcellular water content
• The more K, the less Na. The less K, the more Na
• Plays a vital role in such processes such as transmission of electricalimpulses, particularly in nerve, heart, skeletal, intestinal and lung tissue;CHON and CHO metabolism; and cellular building; and maintenance ofcellular metabolism and excitation
• Assists in regulation of acid-base balance by cellular exchange with H
• RDA: not known precisely. 50-100 mEq
• Sources: bananas, peaches, kiwi, figs, dates, apricots, oranges,prunes, melons, raisins, broccoli, and potatoes, meat, dairy products
• Excreted primarily by the kidneys. No effective conserving mechanism
• Conserved by sodium pump and kidneys when levels are low
• Aldosterone triggers K excretion in urine
• Normal value: 3.5 – 5 mEq/L
O O
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 55/132
CAUSES AND EFFECTS OF HYPOKALEMIA• Known as a low level of serum potassium, less than 3.5 mEq/L
Decreased Intake
↓ Food and Fluids as in
starvation
Failure to replace GIlosses
Increased Loss
↑ Aldosterone Gastrointestinal losses
Potassium-losing diureticsLoss from cells as in trauma,
burns
Shift of Potassium
into Cells
(No change in totalbody potassium)
HYPOKALEMIA
GI Tract
AnorexiaN&V
Abdominal
distention
CNS
Lethargy,Diminished
deep-tendonreflexes,
Confusion,Mental
depression
Muscles
Weakness,Flaccid paralysis,
Weakness ofrespiratorymuscles,
Respiratory arrest
CV System
Decrease instanding BP,
Dysrhythmias,ECG changes,
Myocardialdamage, Cardiac
arrest
Kidneys
↓Capacity to
concentratewaste, waterloss, thirst,
kidneydamage
PATHOPHYSIOLOGY OF HYPOKALEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 56/132
= Action Potential
Nerve and Muscle Activity
Low
ExtracellularK+
Increase in
restingmembranepotential
The cellbecomes
lessexcitable
Ald t i t d
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 57/132
Sodium is retained in the body through resorption by
the kidney tubules
Potassium is excreted
Aldosterone is secreted
Use of certain diuretics such as thiazides and furosemide, andcorticosteroids
Increased urinary output
Loss of potassium in urine
COLLABORATIVE CARE MANAGEMENT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 58/132
COLLABORATIVE CARE MANAGEMENT
• Being alert to the conditions that cause potassium depletion such asvomiting, diarrhea and diuretics, by monitoring the patient for earlywarning signs
• No more than 3 enemas without consulting a physician
• Education about the importance of adequate dietary intake ofpotassium
• In severe hypokalemia, a patient may die unless potassium isadministered promptly
• The safest way to administer K is orally. When K is given IV, the rateof flow must be monitored closely and should be diluted. Should notexceed 20 mEq/hr
• If PO, taken with at least ½ glass of water
• Cardiac monitoring is useful
• Potassium sparing diuretics such as triamterene, spironolactone, etc• Symptoms of K depletion: muscle weakness, anorexia, nausea and
vomiting = appropriate referral
CAUSES AND EFFECTS OF HYPERKALEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 59/132
• Serum potassium level greater than 5.5 mEq/L
Excess Intake
Dietary intake of excess
of kidney’s ability toexcrete; Excess
parenteral administration
Decreased Loss
Potassium-sparing diuretics;Renal failure; Adrenal
insufficiency
Shift of Potassiumout of the Cells
Extensive injuries,crushing injuries,
metabolic acidosis
HYPERKALEMIA
GI Tract
N&VDiarrhea,
Colic
CNS
Numbness,paresthesias
Muscles
Early: irritability
Late: weaknessleading to flaccid
paralysis
CV System
Conductiondisturbance,ventricular
fibrillation,Cardiac Arrest
Kidneys
Oligurialeading to
anuria
COLLABORATIVE CARE MANAGEMENT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 60/132
• Patients at risk should be identified: impaired renal function toavoid OTC, esp. NSAIDS which provoke hyperkalemia; and saltsubstitutes that are high in potassium
• Severity guides therapy
– Mild: Withholding provoking agent (i.e., K supp)
– Severe (>6 mEq/L: cation-exchange resin such asKayexalate (act by exchanging the cations in the resin forthe potassium in the intestine potassium is then excretedin the stool; Continuous cardiac monitoring
• Bowel function must be maintained if Kayexelate therapy is tobe effective
• Potassium-wasting diuretics may be prescribed to promotefurther potassium loss. Dialysis for patients with renal failure to
eliminate excess potassium
• Intravenous Ca Gluconate may be prescribed to counteract thecardiac effects of hyperkalemia
• Insulin infusions and IV NaCO3 may be used to promoteintracellular uptake of K
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 61/132
CAUSES AND EFFECTS OF HYPOCALCEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 62/132
DecreasedIonized Ca
Large
tranfusion withcitrated blood
Excess Loss
Kidney Disease
Decrease in GI Tractand Bone Absorption
↑Magnesium
↑Calcitonin
↓Vitamin D ↓Parathyroid Hormone
HYPOCALCEMIA
Bones
Osteoporosisleading to
Fractures
CNS
Tingling
↓convulsions
Other
Abnormaldeposits
of calcium
in bodytissues
Muscles
Muscle spasm
↓
Tetany
CardiovascularSystem
Dysrhythmias
↓ Cardiac arrest
InadequateIntake
Dietary Deficit
PATHOPHYSIOLOGY OF HYPOCALCEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 63/132
PATHOPHYSIOLOGY OF HYPOCALCEMIA•Calcium ions are thought to line thepores of cell membranes, especially
neurons•Calcium and Sodium repel each other
•When serum calcium levels are low, thisblocking effect is minimized
•When Sodium moves more easily intothe cell, depolarization takes place moreeasily
•This results in increased excitability ofthe nervous system leading to musclespasm, tingling sensations, and if severe,convulsions and tetany
•Skeletal, smooth, and cardiac musclefunctions are all affected by
overstimulation
Sodium Calcium
CLINICAL MANIFESTATIONS OF HYPOCALCEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 64/132
COMPLAINT OF NUMBNESS AND TINGLING OF EARS, NOSE,FINGERTIPS OR TOES
TREATMENT
PAINFUL MUSCULAR SPASMS (TETANY)ESPECIALLY OF FEET AND HANDS
(CARPOPEDAL SPASMS), MUSCLE TWITCHINGAND CONVULSIONS MAY FOLLOW
TESTS USED TO ELICIT SIGNS OF CALCIUM DEFICIENCY
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 65/132
TESTS USED TO ELICIT SIGNS OF CALCIUM DEFICIENCY
COLLABORATIVE CARE MANAGEMENT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 66/132
• Identify risk factors: Inadequate calcium intake, excess calcium loss,Vitamin D deficiency, patients with poor diets
• Education about the importance of adequate calcium and Vitamin Dintake
• Patients undergoing thyroid, parathyroid, and radical neck surgery areparticularly vulnerable to hypocalcemia secondary to parathyroidhormone deficit
• Monitoring of serum calcium levels and correction of deficits
• Citrate is added to store blood to prevent coagulation.
• Citrate + Transfusion = Citrate+Calcium• Normally, Liver + Citrate = Quick metabolism
• Preexisting calcium deficit/hepatic dysfunction/large amounts of BTvery rapidly = hypocalcemia
• With acute hypocalcemia, Ca Gluconate is used + Continuous cardiacmonitoring
• Mild Hypocalcemia: High calcium diet or oral calcium salts
• If PTH or Vit D Deficiency is the cause: aluminum hydroxide gel isused because when serum phosphate level rises, calcium level falls
• Complication: Bone demineralization
• Therefore, careful ambulation should be encouraged to minimize bone
resorption
HYPERCALCEMIA: Serum concentration > 10mg/dLCauses and Effects
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 67/132
Causes and Effects
Loss from bones
Immobilization,
Carcinoma with bonemetastases, Multiple
myeloma
Excess Intake
↑ Calcium diet (esp. milk) Antacids containing calcium
Increase in factorsCausing Mobilization
from bone↑PTH, ↑ Vitamin D,
steroid therapy
HYPERCALCEMIA
Kidneys
Stones
↓
KidneyDamage
CNS
↓Deep-tendonreflexes
↓ Lethargy
↓
Coma
Bones
Bone pain
↓
Osteoporosis
↓
Fractures
Muscles
Muscle fatigue,hypotonia
↓
↓ GI motility
CV System
Depressedactivity
↓ Dysrhythmias
↓
Cardiac Arrest
CLINICAL MANIFESTATIONS OF HYPERCALCEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 68/132
Decreased GIMotility
Cardiac Dysrhythmias
Constipation
Nausea
Mental status changes:lethargy, confusion,
memory loss
CLINICAL MANIFESTATIONS OF HYPERCALCEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 69/132
Immobilization BoneDemineralization
Calciumaccumulates in
the ECF andpasses through
the kidneys
Ca PrecipitationCalcium Stones
COLLABORATIVE CARE MANAGEMENT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 70/132
• Mild hypercalcemia: hydration and education about avoiding foods
high in calcium or medications that promote calcium elevation• Ambulation as appropriate; weight-bearing exercises as tolerated
• Trapeze, resistance devices
• Marked hypercalcemia: prevention of pathologic fractures,individualized plan of care
• Prevention of renal calculi: encourage oral fluids to preventconcentrated urine: 3000 to 4000 mL/day unless contraindicated
• Acid-ash fruit juices: cranberry juice and prune juice
• Severe hypercalcemia: medical emergency: continuous cardiac
monitoring, hydration, IV furosemide, Calcitonin and/or plicamycin(mithramycin), q2 serum and urinary electrolytes
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 71/132
• Mostly found within body cells: heart, bone, nerve, and muscle tissues
• Second most important cation in the ICF, 2nd to K+
• Functions: Metabolism of CHO and CHON, protein and DNA synthesis,DNA and RNA transcription, and translation of RNA, maintains normalintracellular levels of potassium, helps maintain electric activity innervous tissue membranes and muscle membranes
• RDA: about 18-30 mEq; children require larger amounts
• Sources: vegetables, nuts, fish, whole grains, peas, and beans
• Absorbed in the intestines and excreted by the kidneys
• Plasma concentrations of magnesium range from 1.5 – 2.5 mEq/L, withabout one third of that amount bound to plasma proteins
HYPOMAGNESEMIA: Serum level < 1.5 mEq/L
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 72/132
HYPOMAGNESEMIA: Serum level < 1.5 mEq/L• Usually coexists with hypokalemia and less often with hypocalcemia
Decreased Intake
Prolongedmalnutrition,Starvation
Impaired absorption from GI Tract
Malabsorption syndrome, Alcohol WithdrawalSyndrome, Hypercalcemia, Diarrhea,
Draining gastrointestinal fistula
ExcessiveExcretion
↑Aldosterone,
Conditionscausing largelosses of urine
HYPOMAGNESEMIA
Mental Changes
Agitation,Depression,
Confusion
CNS
Convulsions,Paresthesias,
Tremor, Ataxia
Muscles
Cramps,Spasticity, Tetany
CV System
Tachycardia,Hypotension,
Dysrhythmias
HYPOKALEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 73/132
PATHOPHYSIOLOGY OF HYPOMAGNESEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 74/132
High Serum Calcium
Increased acetylcholine release
Increased neuromuscular irritability
Increased sensitivity to acetylcholine at the myoneural junction
Diminished threshold ofexcitation for the motor
nerve
Enhancement of myofibrilcontraction
High Serum CalciumExcretion of Magnesium
By the GI tract
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 75/132
PATHOPHYSIOLOGY OF HYPOMAGNESEMIA
MAGNESIUM
INHIBITS TRANSPORT OF PTH
DECREASE IN THE AMOUNT OF CALCIUM BEING RELEASEDFROM THE BONE
POSSIBLE CALCIUM DEFICIT
CLINICAL MANIFESTATIONS OF HYPOMAGNESEMIA
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 76/132
CONFUSION
DEPRESSION
CRAMPS
TETANY CONVULSIONS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 77/132
COLLABORATIVE CARE MANAGEMENT
• Recognition of people at risk: people taking loop diuretics and
digoxin should be encouraged to eat foods rich in magnesium,such as fruits, vegetables, cereals, and milk
• Recognition of signs and symptoms of magnesium deficiency
• Magnesium is essential for potassium resorption, so ifhypokalemia does not respond to potassium replacement,
hypomagnesemia should be suspected
• Treatment of the underlying cause is the first consideration inhypomagnesemia
• Severe: parenteral magnesium replacement is indicated
• IV therapy: continuous cardiac monitoring• Safety measures for patients with mental status changes
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 78/132
HYPERMAGNESEMIA: Serum Mg level 2.5 mEq/L
• Seldom develops in the presence of normal renal function
• May occur as a result of Mg replacement
• May occur when MgSO4 is administered to prevent seizuresresulting from eclampsia
• Careful monitoring is imperative
PATHOPHYSIOLOGY
R l f il E i IV i f i f
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 79/132
Renal failure, Excessive IV infusion ofmagnesium, Decreased GI elimination
and/or absorption, etc.
Accummulation of Mg in the body
Diminishing of reflexes, drowsiness, lethargy
Mg Level Rises
Severe Respiratory Depression
RESPIRATORY ARREST may occur
Altered Electrical Conduction
Slowed heartrate and AV
Block
Peripheralvasodilation
Hypotension, flushing, andincreased skin warmth
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 80/132
COLLABORATIVE CARE MANAGEMENT• Identification of patients at risk: those with impaired renal
function to avoid OTC that contain magnesium such as Milk ofMagnesia and some Mg-containing antacids
• Any patient receiving parenteral magnesium therapy should beassessed frequently for signs of hypermagnesemia
• Mild hypermagnesemia: withholding magnesium-containing
medications may suffice• Renal failure: dialysis
• Severe: may require treatment with calcium gluconate (10-20mL of 10% Ca Gluconate administered over 10 minutes)
• If cardiorespiratory collapse is imminent, the patient may
require temporary pacemaker and ventilator support
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 81/132
NURSING MANAGEMENT OFPATIENT WITH FLUID AND
ELECTROLYTE IMBALANCES
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 82/132
Parameter_____Fluid Excess___ Fluid Loss/Electrolyte Imbalance____
Behavior Tires easily; Change in behavior, confusion, apathy
Head, neck Facial edema, distended neck Headache, thirst, dry mucous membranesveins
Upper GI Anorexia, nausea, vomiting
Skin Warm, moist, taut, cool feeling Dry, decreased turgor whereedematous
Respiration Dyspnea, orthopnea, productive Changes in rate and depth of respirationcough, moist breath sounds
Circulation Loss of sensation in edematous Pulse rate changes, dysrhythmia,postural areas, pallor, bounding pulse,
increased blood pressure hypotension
Abdomen Increased girth, fluid wave Distention, abdominal cramps
Elimination Constipation Diarrhea, constipation
Extremities Dependent edema, “pitting” Muscle weakness, tingling, tetany ,discomfort from weight ofbedclothes
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 83/132
Pitting edema
Dependent edema
Refractory Edema
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 84/132
LABORATORY VALUES
FLUID DEFICIT FLUID EXCESS
Hemoconcentration Hemodilution
↑ Hct, BUN, E+ levels ↓ Hct, BUN, E+ levels
↑ Urine Specific Gravity ↓ Urine Specific Gravity
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 85/132
Determined from analysis of patient data
Diagnostic Title Possible Etiologic Factors
1 Deficient fluid volume Active fluid volume loss
(hemorrhage, diarrhea, gastricintubation, wounds, diaphoresis),inadequate fluid intake, failure ofregulatory mechanisms,sequestration of body fluids
2 Excess Fluid Volume Excess fluid intake, excess sodium
intake, compromised regulatoryprocesses
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 86/132
EXPECTED PATIENT OUTCOMES
1. Will maintain functional fluid volume as evidenced byadequate urinary output, stable weight, normal vital
signs, normal urine specific gravity, moist mucus
membranes, balanced intake and output, elastic skin turgor,prompt capillary refill, and absence of edema
2. Will verbalize understanding of treatment plan andcausative factors that led to the imbalance
1,2 Intake and Output Monitoring
- Type and amount of fluid the patient has received and the
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 87/132
yp proute by which they were administered
- Record of solid food intake. Gelatin or Popsicles arerecorded as fluids
- Ice chips are recorded by dividing the amount of chipsby ½ (60 mL of chips = 30 mL water)
- Accurate output record and described by color, content,and odor (Normally, gastric contents are watery and paleyellow-green; they usually have a sour odor)
- With acid-base balance upset, gastric secretions may
have a fruity odor because of ketone bodies- Bile: thicker than gastric juice, dark green to brown,
acrid odor, bitter taste when vomiting
- NGT irrigation added to intake
- Stools: difficult to estimate amount; consistency, color,and number of stools provide a reasonable estimate
- Peritoneal or pleural fluid drainage is recorded as outputas with its amount, color, and clarity
- Character and volume of urine. Place signs andmaterials so that an accurate record of UO is
maintained
1,2 Intake and Output Monitoring
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 88/132
, p g
- Evaluate and refer urine specific gravity as appropriate(normal value is 1.003 – 1.030). The implications are:
High Dehydration
Low SIADH, overhydration
- Drainage, fluid aspirated from any body cavity must bemeasured. With dressings, fluid loss is the differencebetween the wet dressings and the dry weight of thedressing
- Accurate recording of the temperature to help thephysician determine how much fluid should be
replaced
1,2 Daily Weight
- Evaluate trends in weight (An increase in 1kg in weight
is equal to the retention of 1L of fluid in an edematouspatient)
Considerations:
- Daily weights early in the morning after voidingbut before he or she has eaten or defecated
1 Replacement of Fluid and Electrolytes
G l P i i l
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 89/132
General Principles:
- Either by oral intake (healthiest way), tube feeding,intravenous infusion, and/or total parenteral nutrition
- Normal saline solution and plain water should also begiven by slow drip to replace daily fluid loss
- IV administration per doctor’s orders
- Fluid replacement considerations:
* Most effective when apportioned over 24 hr period
(Better regulation, ↓potential for calculi formation andsubsequent renal damage, ↓potential for circulatoryoverload which may cause in fluid and electrolyte
shifts)
* Administer concentrated solutions of Na, Glucose orprotein because they require body fluids for dilution
* Consider the size of the patient (small adult has lessfluid in each compartment, especially in the
intravascular compartment)
- Promote oral intake as appropriate
* Caution with coffee, tea, and some colas
* small amount at frequent intervals is more useful than a
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 90/132
qlarge amount presented less often
* Always give consideration to cultural and aestheticaspects of eating
- Give mouth care to a dehydrated patient before and after mealsand before bedtime (Xerostomia may lead to disruption of tissues inthe oral cavity)
- Avoid irritating foods
- Stimulation of saliva may be aided by hard candy or chewinggum or carboxymethylcellulose (artificial saliva)
- Keep lips moist and well lubricated- Give salty broth or soda crackers for sodium replacement and
tea or orange juice for potassium replacement as appropriate.Bananas, citrus fruits and juices, some fresh vegetables, coffee, andtea are relatively high in potassium and low in sodium. Milk, meat,eggs, and nuts are high in protein, sodium and potassium.
- Offer milk for patients with draining fistulas from any portion of theGI tract. Lactose intolerance is not necessarily a
contraindication (Lactase enzyme preparations are available)
- Increase usual daily requirement of foods when losses must berestored, as tolerated
* Patients with cardiac and renal impairments are
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 91/132
pinstructed to avoid foods containing high levelsof sodium, potassium and bicarbonate
- Administer replacement solutions through tube feeding as is
* Either water, physiologic solution of NaCl, high proteinliquids, or a regular diet can be blended, diluted andgiven by gavage
* The water content in the tube feeding needs to beincreased if:
1 the patient complains of thirst2 the protein or electrolyte content of the tube
feeding is high
3 the patient has fever or disease causing anincreased metabolic rate
4 UO is concentrated5 signs of water deficit develop
- Administer parenteral fluids as necessary
* Types of solutions
- D5W (hypotonic) is given short-term for hyponatremia
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 92/132
D5W (hypotonic) is given short term for hyponatremia
- D5NSS may be given depending on the serum levels ofsodium and vascular volume + KCl to meet normalintake needs and replace losses for hyponatremia
- Dextrose 5% in 0.2% normal saline is generally used asa maintenance fluid
- Dextrose 5% in ½ normal saline is generally used as areplacement solution for losses caused by
gastrointestinal drainage
- PNSS is given primarily when large amounts of sodium
have been lost and for patients with hyponatremia- LRS is also isotonic because it remains in the
extracellular space
- Fructose or 10-20% glucose in distilled water arehypertonic solutions and may partially meet bodyneeds for CHOs
- Dextran (commonly-used plasma expander) increasesplasma volume by increasing oncotic pressure. Maycause prolonged bleeding time and is CI in patientswith renal failure, bleeding disorders, or severe CHF
* Administration- The rate should be regulated according to the patient’s
needs and condition per doctor’s orders
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 93/132
needs and condition per doctor s orders
- Monitor UO carefully. Refer marked decreases!
- Verify orders for potassium administration in patients
with renal failure and untreated adrenal insufficiency- Usual rate for fluid loss replacement: 3ml/min
- Recognize signs of pulmonary edema (bounding pulse,engorged peripheral veins, hoarseness, dyspnea,
cough, and rales) that can result from ↑IV rate
- If infiltration occurs, the infusion should be stopped
immediately and relocated. Peripheral IV sites aregenerally rotated every 72 hours
- For dextran and other plasma expanders, observe foranaphylactic reaction (apprehension, dyspnea,wheezing, tightness of chest, angioedema,itching, hives and hypotension). If this happens,
switch infusion to nonprotein solution and run at KVOrate, notify physician and monitor VS
- Pronounced and continued thirst despite administrationof fluids is not normal and should be reported (may
indicate DM or hypercalcemia)
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 94/132
* Patient/Family Education
- Include the signs and symptoms of water excess indischarge instructions
- With drug therapy, instruct patient and family regardingcorrect method of administration, correct dose, andtherapeutic and adverse effects
- Instruct to read labels for nutritional content
* For K restriction: avoid organ meats, fresh and driedfruits, and salt substitutes
- Skin assessment and care, positioning techniques forpatients with mobility restrictions
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 95/132
* Achievement of outcomes is successful in disturbances in fluidand electrolyte balance:
1 Maintains functional fluid volume level with adequate UO,VS within the patient’s normal limits, sp gr of urinewithin 1.003-1.035, moist mucous membranes, stableweight, Intake=output, elastic skin turgor, and no edema
2 States possible causes of imbalance and plan to preventrecurrence of imbalances
3 Reports a decrease or absence of symptoms causing
discomfort
Fluids and Electrolytes
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 96/132
Fluids and Electrolytes
Acid-base
balance
DRAWING ARTERIAL BLOOD GASES
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 97/132
DRAWING ARTERIAL BLOOD GASES
ALLEN’S TEST ARTERIAL PUNCTURE
NORMAL ACID-BASE BALANCE
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 98/132
Estimated HCO3 concentration after fullyoxygenated arterial blood has beenequilibrated with CO2 at a PCO2 of 40mmHg at 38C; eliminates the influence ofrespiration on the plasma HCO3concentration
22-26 mEq/LStandard HCO3
Partial pressure of CO2 in the arterialblood:
PCO2<35 mmHg = respiratory alkalosis
PCO2>45 mmHg = respiratory acidosis
35-45 mmHgPaCO2
Identifies whether there is acidemia oralkalemia:
pH<7.35 = acidosis; pH>7.45 = alkalosis7.35-7.45pH
Partial pressure of oxygen in arterialblood (decreases with age)
In adults < 60 years:
60-80 mmHg = mild hypoxemia
40-60 mmHg = moderate hypoxemia
< 40 mmHg = severe hypoxemia
80-100 HgPaO2
Definition and ImplicationsNormal ValueParameter
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 99/132
S C G O O C S C
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 100/132
BASIC REGULATION OF ACID-BASE BALANCE
CO2 + H2O ↔ H2CO3 ↔ H+ + HCO3
The lungs help control acid-base balance by blowing off orretaining CO2. The kidneys help regulate acid-base balance by
excreting or retaining HCO3
TYPES OF ACID-BASE DISTURBANCES
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 101/132
Depression of the central
nervous system, asevidenced by disorientationfollowed by coma
Overexcitability of thenervous system; muscles
may go into a state of tetanyand convulsioons
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 102/132
EXPECTED DIRECTIONAL CHANGES WITH ACID-BASE IMBALANCES
HCO3 PCO2pHCONDITION
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 103/132
↑
↑
↑
↓
↓
↓
Normal
↓
↓
Normal
↑
↑
HCO3
Normal
↑
↑
↑
↑
Normal
Metabolic Alkalosis
Uncompensated
Partly Compensated
Compensated
Normal
↓
↓
↓
↓
Normal
Metabolic Acidosis
Uncompensated
Partly Compensated
Compensated
↓
↓
↓
↑
↑
Normal
Respiratory Alkalosis
Uncompensated
Partly Compensated Compensated
↑
↑
↑
↓
↓
Normal
Respiratory Acidosis
Uncompensated
Partly Compensated
Compensated
PCO2pHCONDITION
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 104/132
Compensation
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 105/132
p
RESPIRATORY ACIDOSIS: CARBONIC ACID EXCESS
D t th i t t i th d ll d ti b t ti
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 106/132
Damage to the respiratory center in the medulla, drug or narcotic use, obstructionof respiratory passages, respiratory and respiratory muscle disorders
Decrease in the rate of pulmonary ventilation
Increase in the concentration of CO2, carbonic acid,and hydrogen ions
RESPIRATORY ACIDOSIS
Potassium moves out of the cells
HYPERKALEMIA
VENTRICULAR FIBRILLATION
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 107/132
NURSING MANAGEMENT OF RESPIRATORY ACIDOSIS
ASSESSMENT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 108/132
* Health Hx: complaints of headache, confusion, lethargy,nausea, irritability, nausea, irritability, anxiety, dyspnea, and
blurred vision, preexisting conditions
* Physical Examination: lethargy to stupor to coma, tachycardia,hypertension, cardiac dysrhythmias, airway patency
NURSING DIAGNOSES include but are not limited to:
Diagnostic Title Possible Etiologic Factors1 Impaired gas exchange Hypoventilation
2 Disturbed thought processes Central nervous system depression
3 Anxiety Hypoxia, hospitalization
4 Risk for ineffective family Illness of a family member
coping5 Ineffective airway clearance Hypoventilation, secretions
6 Ineffective breathing pattern Hypoventilation, dyspnea
NURSING MANAGEMENT OF RESPIRATORY ACIDOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 109/132
EXPECTED PATIENT OUTCOMES include but are not limited to:
1 Will maintain airway patency and adequate breathing rate andrhythm will return of ABGs to patient’s normal level
2 Will be alert and oriented to time, place, and person, or to hisor her normal baseline level of consciousness
3 Will cope with anxiety
4 Will exhibit effective coping and awareness of effectivesupport systems
5 Will have secretions that are normal for self in amount and canbe raised
6 Will maintain adequate rate and depth of respirations using
pursed lip and other breathing techniques when necessary (asin the patient with COPD)
NURSING MANAGEMENT OF PATIENT WITH RESPIRATORY ACIDOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 110/132
INTERVENTIONS
1 Supporting effective gas exchange
- Provide a position of comfort to allow ease of respiration
- Obtain and monitor ABG results and VS. Refer accordingly
- Provide and monitor supplemental oxygen as ordered
- Turn the patient q2 and PRN
- Provide pulmonary hygiene PRN
- Maintain adequate hydration
- Provide comfort measures such as mouth care
- Assist with ADLs
- Instruct patient regarding coughing and deep breathing andmanagement of disease condition, especially COPD
2 Coping with disturbed thought processes
- Do frequent neurologic assessments
- Monitor and document person’s baseline LOC frequently
NURSING MANAGEMENT OF PATIENT WITH RESPIRATORY ACIDOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 111/132
- Reorient as necessary by providing calendars, clocks, etc.
3 Relieving anxiety
- Provide a calm, relaxed environment
- Give clear, concise explanations of treatment plans
- Encourage expression of feelings
- Provide support and information to patient and family
- Teach relaxation techniques
- Assist the patient to identify coping mechanisms to deal withanxiety and stress
4 Enhancing coping mechanisms
- Provide support and information to family members about thepatient’s ongoing condition
- Reassure them that there is a physiologic cause for thepatient’s behavior
NURSING MANAGEMENT OF PATIENT WITH RESPIRATORY ACIDOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 112/132
NURSING MANAGEMENT OF PATIENT WITH RESPIRATORY ACIDOSIS
- Encourage questions and open communication
5 Promote airway clearance
- Implement regular breathing and coughing exercises
- Do suctioning as necessary
- Maintain good hydration
- Do chest physiotherapy as appropriate
6 Promoting an effective breathing pattern
- Maintain alveolar ventilation
- Teach the patient proper breathing techniques as well as panic
control breathing
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 113/132
NURSING MANAGEMENT OF PATIENT WITH RESPIRATORY ACIDOSIS
EVALUATION. Achievement of outcomes is successful when the patient:
1a. Demonstrates improved ventilation and oxygenation
1b Has vital signs, ABGs, and cardiac rhythm within own normalrange
2 Returns to baseline LOC
3 Reports reduced anxiety
4 Family uses adequate coping mechanisms
5 Is able to raise secretions on own
6 Demonstrate effective breathing techniques
RESPIRATORY ALKALOSIS: CARBONIC ACID DEFICIT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 114/132
Anxiety, hysteria, fever, hypoxia, pain, pulmonary disorders, lesions
affecting the respiratory center in the medulla, brain tumor,encephalitis, meningitis, hyperthyroidism, gram-negative sepsis
Hyperventilation: Excessive pulmonary ventilation
Decrease in hydrogen ion concentration
RESPIRATORY ALKALOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 115/132
NURSING MANAGEMENT OF RESPIRATORY ALKALOSIS
ASSESSMENT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 116/132
* Health Hx: anxiety, shortness of breath, muscle cramps orweakness, palpitations, panic, dyspnea
* Physical Examination: light-headedness, confusion as a result ofcerebral hypoxia, hyperventilation, tachycardia or arrhythmia,
muscle weakness, (+) Chvostek’s sign or Trousseau’s sign
indicating a low ionized serum calcium level secondary tohyperventilation and alkalosis, hyperactive deep tendon
reflexes, unsteady gait, muscle spasms to tetany, agitation,psychosis, seizures in extreme cases, decreased potassiumlevels
NURSING DIAGNOSES include but are not limited to:
Diagnostic Title Possible Etiologic Factors
1 Anxiety Stress, fear
2 Ineffective breathing pattern Hyperventilation, anxiety
3 Disturbed thought processes CNS excitability; irritability
4 Risk for injury Change in LOC, and potential for
seizures
NURSING MANAGEMENT OF RESPIRATORY ALKALOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 117/132
EXPECTED PATIENT OUTCOMES include but are not limited to:
1 Will report decreased anxiety; verbalizes methods to cope withanxiety
2 Will return to normal respiratory rate and rhythm or at leastdecreased hyperventilation, with return to baseline ABGs
3 Will exhibit reorientation to person, place, and time as perpatient’s baseline
4 Will be free from injury
INTERVENTIONS
1 Allay anxiety
- Give antianxiety medications as ordered
- Have patient breath into a paper bag
- Teach relaxation techniques when initial anxiety attack isover
NURSING MANAGEMENT OF PATIENT WITH RESPIRATORY ACIDOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 118/132
INTERVENTIONS
2 Promoting an Effective Breathing Pattern
- Encourage the patient to slow his or her RR
- Maintain a calm and comforting attitude
- Position the patient to promote maximal ease of inspiration
- Assist the patient with relaxation techniques
3 Coping with Disturbed Thought Processes
- Do frequent reorientation
- Encourage family to participate in patient’s care
- Use simple, direct statements or directions
- Allow the patient adequate time to respond4 Preventing injuries
- Perform neurologic assessment frequently and document
- Institute safety and seizure precautions
- Assess frequently for muscle strength and coordination
NURSING MANAGEMENT OF PATIENT WITH RESPIRATORY ACIDOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 119/132
NURSING MANAGEMENT OF PATIENT WITH RESPIRATORY ACIDOSIS
EVALUATION. Achievement of outcomes is successful when the patient:
1 Reports reduction in anxiety levels
2a Demonstrates effective normal breathing patterns
2b Has ABG results within patient’s normal baseline
3 Returns to normal baseline LOC and orientation level
4 Remains free from injury; no seizure activity
METABOLIC ACIDOSIS: BICARBONATE DEFICIT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 120/132
Increased acid production, uncontrolled diabetes mellitus,
alcoholism, starvation, renal acidosis, lactic acidosis, increased acidingestion, ethanol, salicylates, loss of bicarbonate, severe diarrhea,
intestinal fistulas, adrenal insufficiency, hypoparathyroidism
Excess organic acids are added to body fluids or
bicarbonate is lost
Decrease in bicarbonate concentration
METABOLIC ACIDOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 121/132
NURSING MANAGEMENT OF METABOLIC ACIDOSIS
ASSESSMENT
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 122/132
* Health Hx: anorexia, nausea, vomiting, abdominal pain,headache, thirst if the patient is dehydrated
* Physical Examination: confusion, hyperventilation, warm,flushed skin, bradycardia and other dysrhythmias, decreasing
LOC, nausea, vomiting, diarrhea, Kussmaul respirations, andacetone breath, especially if acidosis is due to ketoacidosis.Symptoms may progress to coma if untreated
NURSING DIAGNOSES include but are not limited to:
Diagnostic Title Possible Etiologic Factors
1 Disturbed thought processes Secondary to CNS depression
2 Decreased cardiac output Dysrhythmias3 Risk for injury Secondary to altered mental state
4 Risk for imbalanced fluid Diarrhea, renal failure
volume
NURSING MANAGEMENT OF METABOLIC ACIDOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 123/132
EXPECTED PATIENT OUTCOMES include but are not limited to:
1 Will return to usual baseline LOC
2 Will return to normal baseline parameters for vital signs withimproved CO and decreased or resolved dysrhythmias
3 Will remain in a safe, secure environment without injury
4 Will maintain fluid and electrolyte balance and stable renal
status
INTERVENTIONS
1 Coping with disturbed thought processes
- Monitor LOC and reorient as necessary
- Monitor VS, esp. RRR, BP, and T
- Monitor ABGs to assess the effects of treatment
- Institute cardiac monitoring as ordered
NURSING MANAGEMENT OF PATIENT WITH METABOLIC ACIDOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 124/132
2 Supporting cardiac output
- Monitor VS, MIO, and fluid and electrolyte balance
- Institute cardiac monitoring to evaluate cardiac status
3 Promoting safety
- Provide a safe, secure and monitored environment
- Institute safety precautions
4 Promoting return of fluid and electrolyte balance
- Monitor MIO
- Administer medications per medical order
NURSING MANAGEMENT OF PATIENT WITH METABOLIC ACIDOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 125/132
NURSING MANAGEMENT OF PATIENT WITH METABOLIC ACIDOSIS
EVALUATION. Achievement of outcomes is successful when the patient:
1 Exhibits baseline-level consciousness and orientation
2 Returns to normal baseline parameters for vital signs andCardiac Output with cardiac dysrhythmias resolved
3 Remains free from injury
4 Maintains fluid and electrolyte balance and stable renal function
METABOLIC ALKALOSIS: BICARBONATE EXCESS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 126/132
Loss of stomach acid, gastric suctioning, persistent vomiting, excess
alkali intake, intestinal fistulas, hypokalemia, Cushing’s syndrome or aldosteronism, potassium-diuretic therapy
Excessive amounts of acid substance and
hydrogen ions are lost from the body or largeamounts of bicarbonate or lactate are added orally
or IV
Excess of base elements
METABOLIC ALKALOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 127/132
NURSING MANAGEMENT OF METABOLIC ALKALOSISASSESSMENT
* Health Hx: Prolonged vomiting or nasogastric suctioning,
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 128/132
g g g g,frequent self-induced vomiting, muscle weakness, light-headedness, ingestion of large amounts of licorice orantacids, use of diuretics, muscle cramping, twitching, or
tingling* Physical Examination: mental confusion, dizziness, changes in
LOC, hyperreflexia, tetany, dysrhthmias, seizurees, respiratoryfailure, positive Chvostek’s or Trosseau’s sign if the patient hasa low ionized serum calcium level, decreased hand grasps,generalized muscle weakness, decreased serum calcium orpotassium level, impaired concentration, seizures, ECG changes
consistent with hypokalemia
NURSING DIAGNOSES include but are not limited to:
Diagnostic Title Possible Etiologic Factors
1 Disturbed thought processes CNS excitation
2 Decreased cardiac output Dysrhythmias and electrolyteimbalances
3 Risk for injury Muscle weakness, tetany, confusion and possibleseizures
4 Risk for imbalanced fluid Nasogastric drainage, diuretic therapy
volume fistula
NURSING MANAGEMENT OF METABOLIC ALKALOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 129/132
EXPECTED PATIENT OUTCOMES include but are not limited to:
1 Will return to usual baseline LOC and orientation
2 Will return to normal baseline parameters for vital signs withimproved CO with resolution of electrolyte imbalances anddecreased or resolved cardiac dysrhythmias
3 Will remain in a safe, secure environment without injury
4 Will maintain fluid and electrolyte balance
INTERVENTIONS
1 Coping with disturbed thought processes
- Monitor LOC and reorient as necessary
- Monitor VS, esp. RRR, BP, and T
- Monitor ABGs to assess the effects of treatment
- Institute cardiac monitoring as ordered
NURSING MANAGEMENT OF PATIENT WITH METABOLIC ALKALOSIS
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 130/132
2 Supporting cardiac output
- Monitor VS, MIO, and fluid and electrolyte balance
- Institute cardiac monitoring to evaluate cardiac status
3 Promoting safety
- Provide a safe, secure and monitored environment
- Institute safety precautions
4 Promoting return of fluid and electrolyte balance
- Monitor MIO
- Administer medications per medical order
NURSING MANAGEMENT OF PATIENT WITH METABOLIC
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 131/132
NURSING MANAGEMENT OF PATIENT WITH METABOLICALKALOSIS
EVALUATION. Achievement of outcomes is successful when thepatient:
1 Manifests mental status has returned to baseline
2 Is free from cardiac dysrhythmias
3 Remains free from injury
4 Maintains fluid balance at baseline level
CRITICAL THINKING EXERCISES
8/4/2019 fluidsandelectrolytes-090305183533-phpapp01
http://slidepdf.com/reader/full/fluidsandelectrolytes-090305183533-phpapp01 132/132
A 32-year-old administrative assistant comes to the urgent carecenter with a 72-hour history of vomiting secondary to influenza.She is lethargic and states, “My muscles are twitching.” Her RR
is 18/min and HR is 110 bpm, T=100.4F. Her blood pressure is110/68 which she states “is about normal for me.” Her ABG
values are as follows:pH: 7.57
PaO2: 92
PaCO2: 41
HCO3: 36Describe her acid-base status, probable cause for the imbalance
and treatment